PATAIGIN, LLC

Medtech · Private

BACLIB, a one-hour microbial identification test that detects species-specific bacterial and fungal lipids directly from blood culture or urine specimens

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$532K
Federal grants
$532K
2 awards · 2021–2023
Rank in peer group#46 of 95
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
6 pending

Capital timeline

202120222023FEDERAL ↑EQUITY ↓Cumulative $532K$257K$276K
202120222023FEDERAL ↑EQUITY ↓Cumulative $532K$257K$276K

Latest events

  • Federal grantHealth and Human S · Phase I · Rapid Microbial ID Direct From Specimen$276K
  • Federal grantHealth and Human S · Phase I · Isotopic Labeling Rapid Antimicrobial Susceptibility Testing$257K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 95 peers

Line = median

Medtech · Instrument

  • Federal grants#46 · top 48%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 6
  • PendingMethods For Determining Growth And ResponseUSPTOApplication 17762332
  • PendingMethod Of Processing SamplesUSPTOApplication 17379795
  • PendingMethod For Analyzing SamplesUSPTOApplication 17287944
Show all 6 patent records
  • Methods For Determining Growth And ResponseNov 17, 2022 · Application 17762332Pending
  • Method Of Processing SamplesJan 27, 2022 · Application 17379795Pending
  • Method For Analyzing SamplesDec 2, 2021 · Application 17287944Pending
  • Methods For Determining Growth And ResponseApplication PCTUS2020052562Pending
  • Method For Analyzing SamplesApplication PCTUS2019058213Pending
  • Method For Data AnalysisApplication PCTUS2018059681Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .